REACH 2.0 is a three-year strategic plan by SHARE INDIA to expand comprehensive non-communicable disease screening across 24 villages in Medchal through a structured, sequential rollout.
The Longitudinal Indian Family Health (LIFE) pilot study was established in 2009. The goal of this study is to understand the link between the environment in which Indian women conceive, pregnancy, and child birth, physical and mental health along with the development of the child.
As part of the Clinical Trial Network established under the National Biopharma Mission through the Biotechnology Industry Research Assistance Council, ten demographic surveillance sites across India were selected to study the epidemiology of acute febrile illnesses, dengue, & chikungunya
STReTCH is a community- and family-based screening program in rural Telangana that integrates molecular diagnostics to identify and manage hypertension, diabetes, tuberculosis, and cervical cancer.
SHARE INDIA jointly with Johns Hopkins University to evaluate various strategies in screening the population for Cervical Cancer. The project was initiated in 2002 and completed in 2009, under the guidance of Prof. Keerti Shah and implemented by his associate Dr. Patti Gravitt.
The Prosthetics & Orthotics for the Differently Abled Program (POP) is an innovation-led initiative focused on developing affordable, customized prosthetic and orthotic solutions in India. By integrating digital technologies with clinical expertise, POP aims to restore mobility, independence, and dignity for persons with limb loss.
Artificial Heart Program (AHP) is a flagship bio-engineering initiative by SHARE INDIA that brings together engineering institutes, medical institutions, and industry partners to advance the indigenous development of life-saving cardiac assist devices in India through collaborative, innovation-driven research.
SHARE INDIA provides technical assistance under cooperative agreements supported by the Centers for Disease Control and Prevention and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to strengthen India’s response to HIV and tuberculosis. Working in close collaboration with national and state health programs, our efforts span disease surveillance systems, laboratory strengthening, diagnostics, treatment optimization, and digital health platforms—advancing data-driven decision-making to accelerate epidemic control and TB elimination.
Supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, SHARE INDIA is strengthening India’s national HIV laboratory systems under NACP by expanding drug resistance testing, improving quality standards, and advancing molecular surveillance. From establishing HIV-1 Drug Resistance laboratories and a national biorepository to scaling ISO 15189–aligned quality systems, this initiative enhances diagnostic accuracy, informs treatment decisions, and strengthens India’s capacity to detect and respond to emerging HIV threats.
The Indian Council of Medical Research (ICMR) the apex governing. body in India for the formulation, coordination and promotion of biomedical research selected SHARE INDIA and MediCiti Institute of Medical Sciences (MIMS) as s sub site of Bhagwan Mahavir Medical Research Center (MMMRC) for a vaccine study.